The range of medical, psychological, and social services designed to help individuals reduce or stop substance use and manage substance use disorders. Treatment may include assessment, counselling and behavioural therapies, medication-assisted treatment, withdrawal management, and support for co-occurring mental or physical health conditions. Effective treatment is typically person-centred and evidence-informed, and may be provided in outpatient, community, or residential settings. Treatment aims to improve health and functioning, reduce substance-related harms, and support individuals in moving toward recovery and long-term wellbeing.
Treatment
Evidence-Based Strategies for Preventing Opioid Overdose
Join the Addiction Policy Forum on March 7th from 1-2:30 p.m. (ET) for a webinar and Q&A to discuss key strategies to preventing opioid overdose with experts from the Centers for Disease Control and Prevention (CDC).
The Clinician’s Guide to Addressing Medical Cannabis in Substance Use Treatment Settings
According to the National Survey on Drug Use and Health, cannabis use rates increased in 2020, with almost 50 million individuals 12 or older reporting use of cannabis in the past year. This increase is reflected in the state-specific data for HHS Region 8 in five of the six states (Colorado, Montana, North Dakota, South Dakota, and Utah).
Staff preferences towards electronic data collection from a national take-home naloxone program: a cross-sectional study
Abstract Background During the scaling-up of a national Norwegian take-home naloxone (THN) program, data collection methods shifted from paper-based to electronic. The aim of this study was to explore staff preferences towards the shift in...
Free ASAM Criteria® Assessment Interview Guide
Source: https://sitefinitystorage.blob.core.windows.net/sitefinity-production-blobs/docs/default-source/quality-science/021122-asam-paper-criteria.pdf?sfvrsn=12032b4a_3 The ASAM Criteria® Assessment Interview Guide is the first publicly...
Effectiveness of e-cigarettes as aids for smoking cessation: evidence from the PATH Study cohort, 2017–2019
Abstract Objective To assess the effectiveness of e-cigarettes in smoking cessation in the USA from 2017 to 2019, given the 2017 increase in high nicotine e-cigarette sales. Methods In 2017, the PATH Cohort Study included data on 3578...
The Synaptic Interactions of Alcohol and the Endogenous Cannabinoid System
ABSTRACT PURPOSE: A growing body of evidence has implicated the endocannabinoid (eCB) system in the acute, chronic, and withdrawal effects of alcohol/ethanol on synaptic function. These eCB-mediated synaptic effects may contribute to the...
Mindfulness-Based Relapse Prevention: why make relapse prevention more mindful?
Traditionally, relapse prevention for addictive disorders has been based on cognitive-behavioural therapy (CBT). The development of mindfulness-based relapse prevention (MBRP) by the University of Washington, which integrates core aspects...
Treatment for substance use disorders: The continuum of care for addiction professionals
The following modules will be covered in the training:
- recovery and recovery management
- factors affecting treatment outcomes
- introduction to motivating and stages of change
- treatment: an overview
- components of treatment: the continuum of care
- evidence-based practices for treatment interventions
Risks and Harms Associated with the Nonmedical Use of Benzodiazepines in the Unregulated Drug Supply in Canada
Summary Substance use risks are significantly higher for people who obtain drugs on the unregulated market as there is no quality control and drug contents are unpredictable. This lack of predictability has increased during the COVID-19...
UNODC supports Practitioners in Community-Based Settings
The South Sumatra province has been ranked as the second largest province with people who use drugs, with a prevalence of 5% which approximately corresponds to 326,694 people, and methamphetamine is still the most popular drug of choice in...